Mazurek Marcin, Mlak Radosław, Homa-Mlak Iwona, Powrózek Tomasz, Brzozowska Anna, Gołębiowski Paweł, Małecka-Massalska Teresa
Department of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland.
II Department of Radiotherapy, Center of Oncology of the Lublin Region St. John of Dukla, 20-059 Lublin, Poland.
J Clin Med. 2020 Dec 14;9(12):4041. doi: 10.3390/jcm9124041.
BACKGROUND: The most serious disturbance of the nutritional status is neoplastic cachexia. The main factor contributing to the development of cachexia is the ongoing inflammatory process. The gene associated with the development of the inflammatory response is . Therefore, the aim of the study was to assess the relationship between a single nucleotide polymorphism (SNP)-323G>A of the gene and the occurrence of nutritional disorders in patients undergoing radiotherapy (RT) due to head and neck cancers (HNC). METHODS: The study involved 71 patients with HNC treated with intensity-modulated radiotherapy (IMRT). SNP analysis of the gene (-323G>A) was performed using commercial molecular probes and Real-Time PCR. RESULTS: The presence of the A allele of the gene significantly (over 14-fold) reduced the risk of severe disturbances in nutritional status assessed according to the subjective global assessment (SGA) scale (odds ratio (OR) = 0.07; = 0.0213). The GG genotype of this gene was associated with an over three-fold higher risk of shortened overall survival (OR = 3.01; = 0.0376). CONCLUSIONS: Determination of the SNP (-323G>A) of the gene may prove to be a useful marker in the assessment of the risk of nutritional disorders in patients with HNC undergoing RT.
背景:营养状况最严重的紊乱是肿瘤恶病质。导致恶病质发展的主要因素是持续的炎症过程。与炎症反应发展相关的基因是 。因此,本研究的目的是评估基因单核苷酸多态性(SNP)-323G>A与因头颈癌(HNC)接受放疗(RT)的患者营养紊乱发生之间的关系。 方法:本研究纳入71例接受调强放疗(IMRT)的HNC患者。使用商业分子探针和实时荧光定量PCR对基因(-323G>A)进行SNP分析。 结果:根据主观全面评定(SGA)量表评估,基因A等位基因的存在显著(超过14倍)降低了严重营养状况紊乱的风险(优势比(OR)=0.07; =0.0213)。该基因的GG基因型与总生存期缩短的风险高出三倍以上相关(OR = 3.01; = 0.0376)。 结论:基因SNP(-323G>A)的测定可能被证明是评估接受RT的HNC患者营养紊乱风险的有用标志物。
J Cancer Res Clin Oncol. 2018-5-25
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020-5-26
Life Sci Alliance. 2023-12
J Clin Med. 2021-2-3
Cancer Manag Res. 2020-7-9
Bratisl Lek Listy. 2019
Curr Opin Rheumatol. 2019-3
J Cancer Res Clin Oncol. 2018-5-25
Front Med (Lausanne). 2018-3-15
Front Oncol. 2017-5-22